Article
NAD pool as an antitumor target against cancer stem cells in head and neck cancer
3 Mar 2023
Abstract excerpt
Summary Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors that affect different anatomical locations. Despite this heterogeneity, HNSCC treatment depends on the anatomical location, TNM stage and resectability of the tumor. Classical chemotherapy is based on platinum-derived drugs (cisplatin, carboplatin and oxaliplatin), taxanes (docetaxel, paclitaxel) and 5-fluorouracil1. Despite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
